PharmTech News

Articles

Catalent’s new Biologics & Specialty Drug Delivery unit will be led by Barry Littlejohn; Jonathan Arnold to lead Oral Drug Delivery.

Catalent Closes Cook Pharmica Acquisition; Defines New Business Units

Scott Gottlieb, MD, went before the House Committee on Energy and Commerce to give members the agency’s view on how to fight the opioid crisis, stressing the use of long-term treatment with drug therapy.


FDA Commissioner Testifies Before House Committee About the Agency’s Efforts to Combat the Opioid Crisis

This approval marks the second gene therapy to be approved by FDA and the first to be approved for certain types of non-Hodgkin lymphoma.

FDA Approves Kite’s CAR-T Drug, Second Gene-Therapy in US

Baxter and FDA are working together to prevent shortages of the company’s sodium chloride 0.9% injection bags after recent hurricanes damaged the island.


FDA and Baxter Work Together to Secure Manufacturing in Puerto Rico

AbbVie, Amgen, AstraZeneca, Bristol-Myerse Squibb, and Eli Lilly and Company said they are working to restore normal operations at their respective facilities and continuing recovery efforts.

Pharma Gives Update on Puerto Rico Manufacturing Operations

Staff survey on the relocation of EMA indicates that the future of public health in Europe is at stake.

EMA Provides Update on Relocation Preparedness and Impact on Staff Retention

The acquisition adds to Catalent’s capabilities in biologics development, analytical services, manufacturing, and finished product supply. 

Catalent to Acquire Cook Pharmica for $950 Million

FDA cited Meridian Medical Technologies, a Pfizer company, which manufactures Mylan’s EpiPen, for cGMP violations that included failure to appropriately investigate defects in auto-injector components. 

FDA Issues Warning Letter to EpiPen Manufacturer

Faced with unprecedented flooding from Hurricane Harvey and days of persistent rain, Arkema’s Crosby, TX, plant lost all power, causing flammable chemicals to ignite.

Explosions Rock Arkema’s Texas Peroxides Plant

FDA approves Novartis’ CAR-T therapy, marking the first time a cell therapy based on gene transfer has been approved in the United States for any indication.

Top News